Researchers find trends among physical and emotional challenges associated with being the primary family caregiver of a patient with multiple myeloma.
Takeda will work with Memorial Sloan Kettering Cancer Center to develop CAR-T therapies for multiple myeloma.
This study sought to determine the noninferiority of 2 hours of cryotherapy vs standard 7 hours prior to high-dose melphalan before autologous HSCT.
An international study sought to determine if ixazomib maintenance after autologous stem cell transplantation would improve progression-free survival and overall survival.
Continuous therapy appears to be the preferred treatment modality in newly diagnosed patients with multiple myeloma (MM).